C-Path’s TRxA launches 2024 grants to boost next-gen therapeutics

Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants, also known as BRIDGe.

Aspartame intake and cancer risk: What you need to know

Aspartame is a low-calorie sweetener that is approximately 200 times sweeter than sugar and is used to replace sugar and provide sweetness in energy-reduced food,

July 14, 2023

Early cholesterol spikes fuel atherosclerosis by altering macrophages

Early intermittent hyperlipidemia significantly accelerates atherosclerosis by disrupting macrophage function, highlighting the need for early cholesterol management.

September 6, 2024

Study finds most patients in TARGET-NASH registry meet revised MASLD criteria – Pharmaceutical Technology

Image credit: Shutterstock/Peakstock Analytics firm Target RWE has published its findings that 99% of participants in TARGET-NASH, a research registry of patients with nonalcoholic fatty

June 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.